27
total announcements
MANGALAM.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 21 Oct 2026
Market Cap
₹48 Cr
EPS (TTM)
₹-24.16
52W Low
₹22.80
52W High
₹73.00
Dividend Yield
0.00%
Beta
0.32
Price / Book
0.5
Debt / Equity
109.4
Revenue (TTM)
₹232 Cr
Gross Margin
35.16%
Operating Margin
-5.38%
Mangalam Drugs And Organics Limited
Mangalam Drugs And Organics Limited has informed the Exchange regarding Change in Auditors of the company. The company has appointed M/s SN. Nanda & Co as the Statutory Auditors for a term of five consecutive years, commencing from the conclusion of the 53rd AGM till the conclusion of the 58th AGM, subject to the approval of the shareholders at the ensuing AGM.
Mangalam Drugs And Organics Limited
Mangalam Drugs And Organics Limited has announced its unaudited financial results for the quarter ended June 30, 2026, with the statutory auditors not expressing any modified opinions in their limited review reports. The company has also appointed new secretarial auditors and statutory auditors for a period of five consecutive years.
Mangalam Drugs And Organics Limited
Mangalam Drugs And Organics Limited has informed the Exchange about the resignation of its Secretarial Auditor, M/s. Ragini Chokshi & Co., due to pre-occupancy with professional commitments, effective from August 4, 2026.
Mangalam Drugs And Organics Limited
Mangalam Drugs And Organics Limited has informed the Exchange about default on its loan obligations to Bank of Baroda and Bank of Maharashtra for a period exceeding 30 days.
Mangalam Drugs And Organics Limited
Mangalam Drugs And Organics Limited has defaulted on its loan obligations to Bank of Baroda and Bank of Maharashtra for a period exceeding 30 days, as per the regulations of the exchange.
Mangalam Drugs And Organics Limited
Mangalam Drugs And Organics Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018. The company has attached the Compliance Certificate as received from MUFG Intime India Private Limited, Registrar and Share Transfer Agent, for the period from April 01, 2026 to June 30, 2026.
Mangalam Drugs And Organics Limited
Mangalam Drugs And Organics Limited has informed the Exchange regarding the closure of the trading window for its designated persons due to the declaration of unaudited financial results for the period ended June 30, 2026.